PRIMA RAY: Open Payments
NPI 1083270912 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 66 payments from 18 companies in 2025. Trend: 2023 $1,171 · 2024 $1,686 · 2025 $1,306
Food & beverage: $1,306
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $185 |
| ABBVIE INC. | 14 | $183 |
| Novo Nordisk Inc | 8 | $177 |
| Abbott Laboratories | 3 | $176 |
| Lilly USA, LLC | 10 | $157 |
| PFIZER INC. | 4 | $79 |
| Amgen Inc. | 3 | $60 |
| Exact Sciences Corporation | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| Dexcom, Inc. | 1 | $42 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, FARXIGA, AIRSUPRA, Ozempic, NURTEC ODT, Wegovy, UBRELVY.
Industry payments across SC — which companies pay providers there.
